Plasma and tissue expression of the long pentraxin 3 during normal pregnancy and preeclampsia.
Rovere-Querini, Patrizia; Antonacci, Simona; Dell'Antonio, Giacomo; Angeli, Anna; Almirante, Giada; Cin, Elena Dal; Valsecchi, Luca; Lanzani, Chiara; Sabbadini, Maria Grazia; Doglioni, Claudio; Manfredi, Angelo A; Castiglioni, Maria Teresa.
; 108(1): 148-55, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16816069
VEGF and VEGFR1 levels in different regions of the normal and preeclampsia placentae.
Expression and clinical significance of ATP-binding cassette transporter 1 in serum and placental tissue in Chinese patients with preeclampsia.
Preeclampsia and Extracellular Vesicles.
HLA gene expression is altered in whole blood and placenta from women who later developed preeclampsia.
The Use of Soluble FMS-like Tyrosine Kinase 1/Placental Growth Factor Ratio in the Clinical Management of Pre-eclampsia.
[Detection of novel genetic markers of susceptibility to preeclampsia based on an analysis of the regulatory genes in the placental tissue].
Towards biomarker-based tests that can facilitate decisions about prevention and management of preeclampsia in low-resource settings.
Regional changes of placental vascularization in preeclampsia: a review.
Oxidative stress and endothelial function in normal pregnancy versus pre-eclampsia, a combined longitudinal and case control study.
Increased maternal and fetal cholesterol efflux capacity and placental CYP27A1 expression in preeclampsia.